mci 9038 has been researched along with Lupus Erythematosus, Systemic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Athar, U; Gajra, A; Hudson, J; Husain, J; Lynch, J | 1 |
1 other study(ies) available for mci 9038 and Lupus Erythematosus, Systemic
Article | Year |
---|---|
Prolonged half-life of argatroban in patients with renal dysfunction and antiphospholipid antibody syndrome being treated for heparin-induced thrombocytopenia.
Topics: Anticoagulants; Antiphospholipid Syndrome; Arginine; Cholangiopancreatography, Endoscopic Retrograde; Female; Half-Life; Heparin; Humans; Kidney Failure, Chronic; Lupus Erythematosus, Systemic; Middle Aged; Peritoneal Dialysis; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Treatment Outcome; Warfarin | 2008 |